• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通人群中脂肪肝替代指标的外部验证:巴尼亚卡瓦洛研究

External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study.

作者信息

Foschi Francesco Giuseppe, Conti Fabio, Domenicali Marco, Giacomoni Pierluigi, Borghi Alberto, Bevilacqua Vittoria, Napoli Lucia, Berardinelli Dante, Altini Mattia, Cucchetti Alessandro, Ercolani Giorgio, Casadei-Gardini Andrea, Bellentani Stefano, Gastaldelli Amalia, Tiribelli Claudio, Bedogni Giorgio, Group Bagnacavallo Study

机构信息

Azienda Unità Sanitaria della Romagna, Ospedale degli Infermi, 48018 Faenza, Italy.

Faculty of Medicine and Surgery, University of Bologna, 40138 Bologna, Italy.

出版信息

J Clin Med. 2021 Feb 1;10(3):520. doi: 10.3390/jcm10030520.

DOI:10.3390/jcm10030520
PMID:33535679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867182/
Abstract

We externally validated the fatty liver index (FLI), the lipid accumulation product (LAP), the hepatic steatosis index (HSI), and the Zhejiang University index (ZJU) for the diagnosis of fatty liver (FL) and non-alcoholic fatty liver disease (NAFLD) in the general population. The validation was performed on 2159 citizens of the town of Bagnacavallo (Ravenna, Italy). Calibration was evaluated by calculating the calibration slope and intercept and by inspecting calibration plots; discrimination was evaluated using the c-statistic. The average calibration slope was 1 and the average intercept was 0 for all combinations of outcomes and indices. For the diagnosis of FL, the c-statistic was 0.85 for FLI, 0.83 for ZJU, 0.82 for HSI, and 0.80 for LAP; for the diagnosis of NAFLD, the c-statistic was 0.77 for FLI, 0.76 for ZJU, 0.75 for HSI, and 0.74 for LAP. All indices were strongly correlated with each other. In conclusion, FLI, LAP, HSI, and ZJU perform similarly well to diagnose FL and NAFLD in the Bagnacavallo population, even if FLI has a small advantage as discrimination is concerned.

摘要

我们对外验证了脂肪肝指数(FLI)、脂质蓄积产物(LAP)、肝脂肪变性指数(HSI)和浙江大学指数(ZJU)在普通人群中诊断脂肪肝(FL)和非酒精性脂肪性肝病(NAFLD)的性能。验证工作在意大利拉文纳省巴尼亚卡瓦洛镇的2159名居民中进行。通过计算校准斜率和截距并检查校准图来评估校准情况;使用c统计量评估鉴别能力。对于所有结局和指数的组合,平均校准斜率为1,平均截距为0。对于FL的诊断,FLI的c统计量为0.85,ZJU为0.83,HSI为0.82,LAP为0.80;对于NAFLD的诊断,FLI的c统计量为0.77,ZJU为0.76,HSI为0.75,LAP为0.74。所有指数之间都高度相关。总之,在巴尼亚卡瓦洛人群中,FLI、LAP、HSI和ZJU在诊断FL和NAFLD方面表现相似,尽管就鉴别能力而言FLI略有优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/0a88913e4990/jcm-10-00520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/359c2548f857/jcm-10-00520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/635bafc1b720/jcm-10-00520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/0a88913e4990/jcm-10-00520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/359c2548f857/jcm-10-00520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/635bafc1b720/jcm-10-00520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca3/7867182/0a88913e4990/jcm-10-00520-g003.jpg

相似文献

1
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study.普通人群中脂肪肝替代指标的外部验证:巴尼亚卡瓦洛研究
J Clin Med. 2021 Feb 1;10(3):520. doi: 10.3390/jcm10030520.
2
Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents.青少年超声诊断非酒精性脂肪性肝病的脂肪肝疾病评分系统验证
Dig Liver Dis. 2021 Jun;53(6):746-752. doi: 10.1016/j.dld.2020.11.037. Epub 2020 Dec 14.
3
Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.代谢相关性脂肪性肝病(MAFLD)中非酒精性脂肪性肝病(NAFLD)相关脂肪变性指数的验证及其与 MAFLD 的诊断准确性比较。
Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):394-401. doi: 10.1097/MEG.0000000000002497. Epub 2022 Dec 23.
4
Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.用于鉴别CT诊断的代谢功能障碍相关脂肪性肝病的脂肪变性指数诊断性能比较
Metabolites. 2022 Jul 19;12(7):664. doi: 10.3390/metabo12070664.
5
Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.日本健康体检受检者中使用非侵入性和非成像程序预测非酒精性脂肪性肝病
Diagnostics (Basel). 2021 Jan 16;11(1):132. doi: 10.3390/diagnostics11010132.
6
Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.代谢相关脂肪性肝病无创指标筛查的验证:新疆农村维吾尔族人群的横断面研究。
Eur J Med Res. 2023 Dec 2;28(1):555. doi: 10.1186/s40001-023-01536-2.
7
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.高加索人群中四种非酒精性脂肪性肝病检测评分的比较。
World J Hepatol. 2020 Apr 27;12(4):149-159. doi: 10.4254/wjh.v12.i4.149.
8
Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.用于诊断绝经前女性多囊卵巢综合征伴或不伴非酒精性脂肪性肝病的内脏脂肪指数。
Maturitas. 2018 Oct;116:1-7. doi: 10.1016/j.maturitas.2018.06.013. Epub 2018 Jul 4.
9
External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.使用 1H 磁共振波谱对外脂肝指数和脂滴产品指数进行验证,以在健康对照者和肥胖、胰岛素抵抗个体中识别肝脂肪变性。
Eur J Endocrinol. 2014 Nov;171(5):561-9. doi: 10.1530/EJE-14-0112.
10
Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.验证脂肪肝指数和肝脂肪变性指数在阻塞性睡眠呼吸暂停低通气综合征成人非酒精性脂肪肝疾病筛查中的应用。
Chin Med J (Engl). 2019 Nov 20;132(22):2670-2676. doi: 10.1097/CM9.0000000000000503.

引用本文的文献

1
Thyroid Stimulating Hormone Levels Are Related to Fatty Liver Indices Independently of Free Thyroxine: A Cross-Sectional Study.促甲状腺激素水平与脂肪肝指标相关,独立于游离甲状腺素:一项横断面研究。
J Clin Med. 2025 Mar 31;14(7):2401. doi: 10.3390/jcm14072401.
2
Association between surrogate indices of fatty liver and the risk of colorectal cancer: a cross-sectional United States study.脂肪肝替代指标与结直肠癌风险之间的关联:一项美国横断面研究。
Transl Cancer Res. 2025 Jan 31;14(1):313-326. doi: 10.21037/tcr-24-1444. Epub 2025 Jan 23.
3
External Validation of Serologic Scores for the Detection of Liver Steatosis Among People With HIV.

本文引用的文献

1
Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents.青少年超声诊断非酒精性脂肪性肝病的脂肪肝疾病评分系统验证
Dig Liver Dis. 2021 Jun;53(6):746-752. doi: 10.1016/j.dld.2020.11.037. Epub 2020 Dec 14.
2
The times they are a-changin' (for NAFLD as well).时代在变(非酒精性脂肪性肝病亦是如此)。
J Hepatol. 2020 Dec;73(6):1307-1309. doi: 10.1016/j.jhep.2020.08.028. Epub 2020 Sep 2.
3
Blood biomarkers for the diagnosis of hepatic steatosis in metabolic dysfunction-associated fatty liver disease.
用于检测HIV感染者肝脂肪变性的血清学评分的外部验证
Open Forum Infect Dis. 2024 Jul 31;11(9):ofae411. doi: 10.1093/ofid/ofae411. eCollection 2024 Sep.
4
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies.用于非酒精性脂肪性肝病流行病学和临床研究中无创诊断及监测的肝脏脂肪评分
J Clin Transl Hepatol. 2023 Oct 28;11(5):1212-1227. doi: 10.14218/JCTH.2022.00019. Epub 2023 May 31.
5
Associations of non-invasive indices of liver steatosis and fibrosis with progressive kidney impairment in adults with type 2 diabetes.非侵入性肝脂肪变性和纤维化指标与 2 型糖尿病成人进行性肾损伤的相关性。
Acta Diabetol. 2023 Jun;60(6):827-835. doi: 10.1007/s00592-023-02058-3. Epub 2023 Mar 21.
6
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的诊治进展。
Int J Mol Sci. 2023 Feb 2;24(3):2844. doi: 10.3390/ijms24032844.
7
Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic/glycemic abnormalities.基于代谢/血糖异常分层的代谢相关脂肪性肝病的脂肪肝和代谢标志物的诊断能力。
J Diabetes Investig. 2023 Mar;14(3):463-478. doi: 10.1111/jdi.13966. Epub 2022 Dec 25.
8
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的进展监测和治疗终点评估。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S228-S243. doi: 10.3350/cmh.2022.0401. Epub 2022 Dec 14.
9
Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study: GPS-NAFLD Study.非酒精性脂肪性肝病与意大利初级保健服务中纤维化的风险:GPS-NAFLD 研究:GPS-NAFLD 研究。
Liver Int. 2022 Dec;42(12):2632-2645. doi: 10.1111/liv.15443. Epub 2022 Oct 18.
10
Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity.地中海饮食与超重和肥胖女性脂肪肝的关系。
Nutrients. 2022 Sep 13;14(18):3771. doi: 10.3390/nu14183771.
用于诊断代谢功能障碍相关脂肪性肝病中肝脂肪变性的血液生物标志物。
J Hepatol. 2020 Nov;73(5):1264-1265. doi: 10.1016/j.jhep.2020.06.003. Epub 2020 Aug 21.
4
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?一般人群中常用的肝纤维化生物标志物与肝硬度之间是否存在关联?
Ann Hepatol. 2020 Jul-Aug;19(4):380-387. doi: 10.1016/j.aohep.2020.04.003. Epub 2020 May 12.
5
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study.炎症指标和代谢综合征能否预测癌症发生风险?来自巴尼亚卡瓦洛人群研究的分析。
J Clin Med. 2020 Apr 20;9(4):1177. doi: 10.3390/jcm9041177.
6
What's in a name? Renaming 'NAFLD' to 'MAFLD'.名字里有什么?将“非酒精性脂肪性肝病”重新命名为“代谢功能障碍相关脂肪性肝病” 。 (备注:MAFLD全称为Metabolic Dysfunction-Associated Fatty Liver Disease ,直译为代谢功能障碍相关脂肪性肝病 ,是对NAFLD(Non-alcoholic Fatty Liver Disease,非酒精性脂肪性肝病)的重新命名 。这里如果仅按字面意思翻译,可能不太能理解其背景含义,补充了备注供你参考。)
Liver Int. 2020 Jun;40(6):1254-1261. doi: 10.1111/liv.14478. Epub 2020 Apr 28.
7
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
8
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
9
Validation of clinical prediction models: what does the "calibration slope" really measure?临床预测模型的验证:“校准斜率”到底在衡量什么?
J Clin Epidemiol. 2020 Feb;118:93-99. doi: 10.1016/j.jclinepi.2019.09.016. Epub 2019 Oct 9.
10
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study.意大利北部普通人群中脂肪肝的患病率及危险因素:巴尼亚卡瓦洛研究
BMC Gastroenterol. 2018 Nov 28;18(1):177. doi: 10.1186/s12876-018-0906-8.